PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514978
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514978
Virology Testing Market size was valued at USD 12,900.10 Million in 2023, expanding at a CAGR of 2.90% from 2024 to 2032.
Virology testing refers to a range of laboratory tests used to detect the presence of viruses or viral components in biological samples such as blood, saliva, or tissue. These tests are crucial for diagnosing viral infections, monitoring disease progression, and assessing the effectiveness of Diagnosis.
Virology Testing Market- Market Dynamics
Growing prevalence of viral infections and personalized medicines are expected to propel market demand
The frequency and spread of viral diseases drive the demand for virology testing. Outbreaks of diseases like influenza, HIV, hepatitis, and emerging viruses like Zika and Ebola contribute to the market growth. Growing awareness about viral diseases and the importance of early detection and Diagnosis encourages individuals to undergo screening tests. Public health initiatives, vaccination campaigns, and routine screening programs also fuel market demand. Modern virology testing methods, like point-of-care testing, PCR, and next-generation sequencing, improve sensitivity, specificity, and speed of diagnosis. Market expansion is further fueled by ongoing innovation in data analysis, automation, and assay development.
The need for molecular diagnostics, such as virology testing, is driven by the trend toward personalized medicine and precision healthcare, which aims to customize therapies based on unique viral and genetic profiles. A strong virology testing infrastructure is essential for the early diagnosis, surveillance, and containment of new infectious diseases, as demonstrated by events like the COVID-19 pandemic. To improve pandemic preparedness and response, governments and healthcare institutions place a high priority on investing in virology testing capabilities.
Virology Testing Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.90% over the forecast period (2024-2032)
Based on Type segmentation, the instruments segment was predicted to show maximum market share in the year 2023, owing to its high demand for small instruments & related kits.
Based on Diagnosis segmentation, the PCR-based method segment was the leading Diagnosis in 2023, PCR methods are widely used for detecting viruses & pathogens.
Based on End User segmentation, the hospitals & clinics segment was the leading End User in 2023, owing to the high demand for virology testing at hospitals & clinics.
On the basis of region, North America was the leading revenue generator in 2023, owing to high spending on the healthcare industry.
The Global Virology Testing Market is segmented on the basis of Type, Diagnosis, End User, and Region.
The market is divided into three categories based on Type: instruments, assay kits, and consumables. The instruments segment dominates the market. High demands for antigen and viruses tests using instruments is promoting market growth.
The market is divided into five categories based on the diagnosis: PCR-based method, molecular diagnostics method, mass spectroscopy-based method, immunoassay-based method, and others. The PCR-based method segment dominates the market. The recent COVID-19 pandemic and respiratory diseases are increasing the need for PCR-based method segment demand.
The market is divided into three categories based on End Users: hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. The diagnostic laboratories segment is expected to expand at the highest rate over the forecast period with advancement in technologies.
Virology Testing Market- Geographical Insights
Worldwide, the Virology Testing market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the global market. The United States dominates the virology testing landscape due to factors such as high healthcare expenditure, advanced healthcare infrastructure, and strong R&D capabilities. The Asia-Pacific region presents significant growth opportunities for the virology testing market, fueled by factors such as rising healthcare expenditure, increasing prevalence of viral diseases, and improving access to healthcare services. Key developments include the expansion of diagnostic testing facilities and adoption of rapid testing technologies.
The virology testing market includes a mix of multinational and domestic firms, generic drug manufacturers, and technology drug development companies. Major players in the market engage in forming partnerships, mergers and acquisitions, and investing in research and development to innovate new testing technologies. For example, Abbott has developed molecular and antigen-based tests for viruses such as HIV, hepatitis, and influenza. Abbott has also entered partnerships with organizations like the Bill & Melinda Gates Foundation to expand access to HIV testing in resource-limited settings.
In June 2022, Anitoa, a United States startup company developed a portable PCR molecular assay for monkeypox virus detection.
In 2022, Quidel Corporation a provider of rapid diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic announces antigen testing solutions.